Cited by 222Antifungal resistance and susceptibilityInfection Control in HealthcareYeasts and Rust Fungi Studies

Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance

Open access
Escandón, Patricia, Chow, Nancy A, Caceres, Diego H, Gade, Lalitha, Berkow, Elizabeth L, Armstrong, Paige, Rivera, Sandra, Misas, Elizabeth +15 more·2019·Clinical Infectious Diseases

Abstract

Background: Candida auris is a multidrug-resistant yeast associated with hospital outbreaks worldwide. During 2015–2016, multiple outbreaks were reported in Colombia. We aimed to understand the extent of contamination in healthcare settings and to characterize the molecular epidemiology of C. auris in Colombia. Methods: We sampled patients, patient contacts, healthcare workers, and the environment in 4 hospitals with recent C. auris outbreaks. Using standardized protocols, people were swabbed at different body sites. Patient and procedure rooms were sectioned into 4 zones and surfaces were swabbed. We performed whole-genome sequencing (WGS) and antifungal susceptibility testing (AFST) on all isolates. Results: Seven of the 17 (41%) people swabbed were found to be colonized. Candida auris was isolated from 37 of 322 (11%) environmental samples. These were collected from a variety of items in all 4 zones. WGS and AFST revealed that although isolates were similar throughout the country, isolates from the northern region were genetically distinct and more resistant to amphotericin B (AmB) than the isolates from central Colombia. Four novel nonsynonymous mutations were found to be significantly associated with AmB resistance. Conclusions: Our results show that extensive C. auris contamination can occur and highlight the importance of adherence to appropriate infection control practices and disinfection strategies. Observed genetic diversity supports healthcare transmission and a recent expansion of C. auris within Colombia with divergent AmB susceptibility.

Integrity signals

Registry

Crossref · 10.1093/cid/ciy411

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Escandón, P., Chow, N. A., Caceres, D. H., Gade, L., Berkow, E. L., Armstrong, P., Rivera, S., Misas, E., Duarte, C., Moulton-Meissner, H., Welsh, R. M., Parra, C., Pescador, L. A., Villalobos, N., Salcedo, S., Berrio, I., Varón, C., Espinosa-Bode, A., Lockhart, S. R., Jackson, B. R., Litvintseva, A. P., Beltran, M., & Chiller, T. M.
Affiliations
  • Instituto Nacional de Salud (CO)
  • Centers for Disease Control and Prevention (US)
  • Universidad de Antioquia (CO)
  • Unidad de Investigación en Proteómica y Micosis Humanas, Facultad de Ciencias, Pontificia Universidad Javeriana
  • Hospital Militar Central (CO)
  • Clínica Los Nogales, Bogotá
  • Clínica General del Norte, Barranquilla
  • Grupo de Micología Médica y Experimental, Corporación para Investigaciones Biológicas
  • Fundación Unidad de Cuidados Intensivos Doña Pilar, Cartagena, Colombia
  • Instituto Nacional de Salud, Bogotá, Colombia
Corresponding author
Chow, Nancy A
Venue
Clinical Infectious Diseases
Published
2018-05-16
Volume
68
Issue
1
Pages
15-21
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2804122276
Cited by
222
References
20
Citations by year
2026: 19 · 2025: 23 · 2024: 26 · 2023: 32 · 2022: 15 · 2021: 31 · 2020: 37 · 2019: 30 · 2018: 9
FWCI
20.20
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Clinical Infectious Diseases (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • Institutional Repository University of Antioquia (University of Antioquia) (publishedVersion, cc-by-nc-nd)
Funders
Instituto Nacional de Salud
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
Keywords
Candida auris, molecular epidemiology, amphotericin B resistance, hospital outbreak, environmental contamination, nosocomial transmission, genetic diversity, non-synonymous mutations, antifungal susceptibility, infection control, Colombia
MeSH terms
Whole Genome Sequencing, Amphotericin B, Antifungal Agents, Candida, Candidiasis, Carrier State, Colombia, Environmental Microbiology, Humans, Microbial Sensitivity Tests, Mycological Typing Techniques, Molecular Epidemiology, Drug Resistance, Fungal, Molecular Typing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review